Developing a Point-of-Care Molecular Test to Detect SARS-CoV-2

Abstract

There is a need for widespread testing in India to stop the spread of the novel coronavirus in the population. While RT-PCR is the recommended diagnostic technique, its use is limited to well-equipped laboratories due to the need for specialized instrumentation, reagents and trained personnel. Immunodiagnostic tests are not yet recommended by the WHO for diagnosing active infections. There is a strong need for developing point-of-care molecular tests. Based on our past experience with paperfluidic devices for diagnosing bacterial infections by molecular tests, we propose the development of a diagnostic test for COVID-19. As a platform technology, it could be adapted to other viral outbreaks in future.

PREFACE on the Special Issue ‘Technologies for Fighting COVID-19’

“…Chatterjee and Bandyopadhyay ( 2020 ) developed a technique for detecting taste-contributing agents that is envisaged to have application in the detection of COVID-19. Paul et al ( 2020 ) proposed a diagnostic test based on a paper fluidic device. The device could diagnose bacterial infections through molecular tests.…”